
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover is an episode from FierceBiotech Radio. Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in S...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Feb 4, 2016, 36:41 long, audio available.
Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.
You can listen to Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover online on Radio and Podcast. Open the player on this page to stream the available audio.
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover is an episode from FierceBiotech Radio.
This episode is 36:41 long.
This episode was published on Feb 4, 2016.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover on this page when the episode audio is available from the podcast feed.
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover is from FierceBiotech Radio.
Published Feb 4, 2016 and 36:41 long